73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

by Impact Journals LLCWnt pathway expression in tumors from NeuT/ATTAC mice. Credit: 2022 Yuan et al.A new research paper titled "Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint

Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

by Impact Journals LLCWnt pathway expression in tumors from NeuT/ATTAC mice. Credit: 2022 Yuan et al.A new research paper titled "Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint
Researchers identify protein that controls CAR T cell longevity

Researchers identify protein that controls CAR T cell longevity

byChildren's Hospital of PhiladelphiaLike a lightbulb, CAR T cells designed to kill cancer often burn out due to exhaustion and poor persistence. Doan et al. discovered that a transcription

Researchers identify protein that controls CAR T cell longevity

byChildren's Hospital of PhiladelphiaLike a lightbulb, CAR T cells designed to kill cancer often burn out due to exhaustion and poor persistence. Doan et al. discovered that a transcription
Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA
Paper filter helps make new cancer drug 1000 times cheaper

Paper filter helps make new cancer drug 1000 times cheaper

by Eindhoven University of TechnologyLech-Gustav Milroy demonstrates the simple separation technique that took the place of the very expensive HPLC. In the background you can see HPLC equipment.

Paper filter helps make new cancer drug 1000 times cheaper

by Eindhoven University of TechnologyLech-Gustav Milroy demonstrates the simple separation technique that took the place of the very expensive HPLC. In the background you can see HPLC equipment.
Tumour removal with a cancer cell clear margin

Tumour removal with a cancer cell clear margin

by CORDISCredit: Benjamin Franklin PierceA biopsy reporting that cancer cells are still in the margin indicates a likelihood of cancer cells remaining in the body. An EU-funded project, IMAGINE,

Tumour removal with a cancer cell clear margin

by CORDISCredit: Benjamin Franklin PierceA biopsy reporting that cancer cells are still in the margin indicates a likelihood of cancer cells remaining in the body. An EU-funded project, IMAGINE,
Bolstering fat cells offers potential new leukemia treatment

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Microbiome predicts blood infections in pediatric cancer patients

Microbiome predicts blood infections in pediatric cancer patients

by CU Anschutz Medical CampusBryan Nycz, 3rd-year medical student at the University of Colorado School of Medicine, and scientific mentors show association between microbiome and blood infections

Microbiome predicts blood infections in pediatric cancer patients

by CU Anschutz Medical CampusBryan Nycz, 3rd-year medical student at the University of Colorado School of Medicine, and scientific mentors show association between microbiome and blood infections
Targeted therapy slows progression of advanced prostate cancer

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical
Study reveals proton beam therapy may shorten breast cancer treatment

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat
Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer

Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer

by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe

Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer

by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe
Study reveals lower predictive ability for renal cancer models

Study reveals lower predictive ability for renal cancer models

(HealthDay)—Prospective validation of existing renal cell carcinoma (RCC) prediction models demonstrates a decrease in their predictive ability, according to a study published online June 19 in the&nb

Study reveals lower predictive ability for renal cancer models

(HealthDay)—Prospective validation of existing renal cell carcinoma (RCC) prediction models demonstrates a decrease in their predictive ability, according to a study published online June 19 in the&nb